1. Home
  2. ANAB vs LZB Comparison

ANAB vs LZB Comparison

Compare ANAB & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$63.15

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$40.95

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
LZB
Founded
2005
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
ANAB
LZB
Price
$63.15
$40.95
Analyst Decision
Buy
Strong Buy
Analyst Count
12
1
Target Price
$71.67
$39.00
AVG Volume (30 Days)
485.4K
651.2K
Earning Date
05-08-2026
06-16-2026
Dividend Yield
N/A
2.75%
EPS Growth
91.02
5.11
EPS
N/A
2.47
Revenue
$234,603,000.00
$2,349,433,000.00
Revenue This Year
N/A
$1.89
Revenue Next Year
$52.14
$2.09
P/E Ratio
N/A
$16.52
Revenue Growth
157.01
N/A
52 Week Low
$17.11
$29.03
52 Week High
$73.30
$44.90

Technical Indicators

Market Signals
Indicator
ANAB
LZB
Relative Strength Index (RSI) 59.71 63.21
Support Level $52.32 $36.31
Resistance Level $67.69 $44.90
Average True Range (ATR) 3.05 1.66
MACD 0.99 0.26
Stochastic Oscillator 93.72 58.13

Price Performance

Historical Comparison
ANAB
LZB

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: